NCT03348631 · Interventional trial
Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer
Overall registry status Active not recruiting
Phase 2
Conditions Recurrent Endometrial Endometrioid Adenocarcinoma, Recurrent Malignant Uterine Corpus Neoplasm, Recurrent Ovarian Carcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma, Recurrent Ovarian Endometrioid Adenocarcinoma
Delaware Valley sites
- Asplundh Cancer Pavilion · Willow Grove, PA · Montgomery County
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory